C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/86 (2006.01) A61K 39/00 (2006.01) C07K 14/02 (2006.01) C07K 14/035 (2006.01) C07K 14/105 (2006.01) C07K 14/11 (2006.01) C07K 14/14 (2006.01) C07K 14/235 (2006.01) C07K 14/28 (2006.01) C12N 7/01 (2006.01) C12N 15/32 (2006.01) C12N 15/38 (2006.01) C12N 15/43 (2006.01) C12N 15/46 (2006.01) C12N 15/51 (2006.01)
Patent
CA 2123804
2123804 9311251 PCTABScor01 Replication-competent recombinant viruses, particularly replication-competent recombinant polioviruses, which include (1) exogenous nucleic acid sequences which encode an exogenous polypeptide and (2) a nucleic acid sequence which encodes an artificial proteolytic cleavage site for a viral or cellular protease which proteolytically processes (cleaves) the precursor protein produced by the parent virus and uses therefor. The recombinant precursor is cleaved into the usual array of constituent proteins, freeing the exogenous polypeptide. Replication-competent recombinant viruses are useful as vaccines against bacterial, viral, fungal and yeast infections, parasitic diseases, cancer and allergies.
Andino Raul
Feinberg Mark
Reilly Patricia Anne
Weeks-Levy Carolyn Louise
American Cyanamid Company
Smart & Biggar
The Whitehead Institute For Biomedical Research
LandOfFree
Recombinant viruses comprising artificial proteolytic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant viruses comprising artificial proteolytic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant viruses comprising artificial proteolytic... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1644908